3,341 followers
#Anti-CD52 antibody treatment, #Alemtuzumab, administered in the peak of disese, depletes B cell aggregates in the central nervous system in a mouse model of #MultipleSclerosis https://t.co/ppKoXKsIuo
#Anti-CD52 antibody treatment, #Alemtuzumab, administered in the peak of disese, depletes B cell aggregates in the central nervous system in a mouse model of #MultipleSclerosis https://t.co/ppKoXKsIuo
Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis. https://t.co/SxCfV5GCpY